Macrophages — a perspective target for antineoplastic immunotherapy


  • О.М. Karaman R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology
  • A.V. Ivanchenko R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology
  • V.F. Chekhun R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology



M1/M2 macrophages, malignant tumors, plasticity, polarization


Summary. The review discusses the data on the functional/phenotypic M1/M2 types of macrophages and their chimeric forms, the molecular mechanisms of polarization of these cells, and their role in the development of malignant tumors. Information on the prognostic value of the presence (density and location) of M1/M2 cells in tumor tissue is analyzed. Our own results evidence on the necessity of determination of the functional/phenotypic state of M1/M2 macrophages from different biological niches in the dynamics of tumor growth, in particular in terms of NO level and arginase activity.


Petty AJ, Yang Y. Tumor-associated macrophages: implications in cancer immunotherapy. Immunotherapy 2017; 9: 289–302.

Kzhyshkowska JuG, Gratchev AN. Monocyte and macrophage markers for diagnostics of immunopathologies. Pathogenesis 2012; 10: 14–9 (in Russian).

Sawa-Wejksza K, Kandefer-Szerszen M. Tumor-associated macrophages as target for antitumor therapy. Arch Immunol Ther Exp 2018; 66: 97–111.

Tang X, Mo C, Wang Y. Anti-tumour strategies aiming target tumour-associated macrophages. Immunology 2013; 138 : 93–104.

Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141: 39–51.

Kovaleva OV, Efremov GD, Mikhaylenko DS. Role of tumor-associated macrophages in renal cell carcinoma pathogenesis. Cancer Urol 2017; 1: 20–6 (in Russian).

Rhee I. Diverse macrophages polarization in tumor microenvironment. Arch Pharm Res 2016; 39 (11): 1588–96.

Chekhun VF, Sherban SD, Savtsova ZD. Tumor heterogeneity — dynamical state. Onkologiya 2012; 5: 4–12 (in Ukrainian).

Berezhnaya NM. Role of immune system cells in tumor microenvironment. I. Cells and cytokines — the components of inflammation. Onkologiya 2009; 1: 6–17 (in Russian).

Berezhnaya NM. Role of immune system cells in tumor microenvironment. II. Interaction of the immune system cells with other microenvironment components. Onkologiya 2009; 2: 86–93 (in Russian).

Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992; 176: 287–92.

Das A, Sinha M, Datta S, et al. Monocyte and macrophage plasticity in tissue repair and regeneration. Am J Pathol 2015; 185: 2596–605.

Mills CD, Kincaid K, Alt JM, et al. M-1/M-2 macrophages and theTh1/Th2 paradigm. J Immunol 2000; 164: 6166–73.

Rodrıguez-Prados J-C, Traves P, Cuenca J, et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol 2010; 185: 605–14.

Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010; 11: 889–96.

Murray PJ, Allen JE, Biswas SK, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014; 41: 14–20.

Gordon S, Martinez FO. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958–69.

Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol 2014; 60: 1090–6.

Sarbaeva NN, Ponomareva JV, Milyakova MN. Macrophages: diversity of phenotypes and functions, interaction with foreign materials. Genes Cells 2016; 11: 9–17 (in Russian).

Schaer DJ, Boretti FS, Hongegger A. Molecular cloning and characterization of the mouse CD163 homologue, a highly glucocorticoid-inducible member of the scavenger receptor cysteine-rich family. Immunogenetics 2001; 53: 170–7.

Sakhno LV, Shevela EYa, Chernykh ER. Phenotypic and functional characteristics of the alternative activated macrophages: potential use in regenerative medicine. Immunologiya 2015; 36: 242–6 (in Russian).

Gratchev A, Kzhyshkowska J, Utikal J, Goerdt S. Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages. Scand J Immunol 2005; 61: 10–7.

Sakhno LV, Tikhonova MA, Shevela EY, et al. Phenotypic and functional features of human M2-like macrophages. Bull SB RANS 2014; 34: 18–24 (in Russian).

Koh TJ, Di Pietro LA. Inflammation and wound healing: the role of the macrophage. Expert Rev Mol Med 2011; 13: 23.

Sun YY, Li XF, Meng XM, et al. Macrophage phenotype in liver injury and repair. Scand J Immunol 2017; 85: 166–74.

Zhang F, Wang H, Wang X, et al. TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype. Oncotarget 2016; 7: 52294–306.

Gratchev A, Kzhyshkowska J, Kannookadan S. Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF beta receptor II. J Immunol 2008; 180: 6553–65.

Hao NB, Lü MH, Fan YH, et al. Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012; 2012: 948098.

Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549–55.

Wang Q, Ni H, Lan L, et al. Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages. Cell Res 2010; 20: 701–12.

Lilian Q, Edveena H, Tobias M, et al. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype. Arthritis Res Ther 2017; 19: 245.

Nan W, Hongwei L, Ke Z. Molecular mechanisms that influence the macrophage M1–M2 polarization balance. Immunobiology 2012; 217: 1233–40.

Essandoh K, Li Y, Huo J, Fan GC. MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response. Shock 2016; 46: 122–31.

Sauer RS, Hacke lD, Morsche lL, et al. Toll like receptor (TLR)-4 as a regulator of peripheral endogenous opioid-mediated analgesia in inflammation. Mol Pain 2014; 10: 10.

Nan W, Hongwei L, Ke Z. Molecular mechanisms that influence the macrophage M1–M2 polarization balance. Immunology 2014; 614: 1–9.

Hao L, Xiaoling W, Nie G, et al. Macrophage functional phenotype can be consecutively and reversibly shifted to adapt to microenvironmental changes. Int J Clin Exp Med 2015; 8: 3044–53.

Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage M1-M2 polarization balance. Front Immunol 2014; 5: 614.

Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006; 66: 7390–4.

Jiang J, Lee EJ, Gusev Y, Schmittgen TD. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucl Acids Res 2005; 33: 5394–403.

Lee EJ, Baek M, Gusev Y, et al. Systematic evaluation of microRNA processing patterns in tissues, cells lines and tumors. RNA 2008; 14: 35–42.

Acunzo M, Romano G, Wernicke D, Croce CM. Micro­RNA and cancer — A brief overview. Adv Biol Regul 2014; 57: 1–9.

Sethupathy P. Illuminating microRNA transcription from the epigenome. Curr Genom 2013; 14: 68–77.

Li Z, Chao TC, Chang KY, et al. The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc Natl Acad Sci USA 2014; 111: 1002–7.

Bi Y, Liu G, Yang R. MicroRNAs: novel regulators during the immune response. J Cell Physiol 2009; 218: 467–72.

Huang C, Liu XJ, Qun Zhou, et al. MiR-146a modulates macrophage polarization by inhibiting Notch1 pathway in RAW264.7 macrophages. Int Immunopharmacol 2016; 32: 46–54.

Yingying Z, Mengying Z, Min Z, et al. Expression profiles of miRNAs in polarized macrophages. Int J Mol Med 2013; 31: 797–802.

Graff JW, Dickson AM, Clay G, et al. Identifying functional microRNAs in macrophages with polarized phenotypes. J Biol Chem 2012; 287: 21816–25.

Qian L, Xia H, Qiao Y, et al. The Notch signal mediates macrophage polarization by regulating miR-125a/miR-99b expression. Jing Chen Pages 2019; 29: 833–43.

Zhao JL, Huang F, He F, et al. Forced activation of notch in macrophages represses tumor growth by upregulating miR-125a and disabling tumor-associated macrophages. Cancer Res 2016; 76: 1403–15.

Ying H, Kang Y, Zhang H, et al. MiR-127 Modulates macrophage polarization and promotes lung inflammation and injury by activating the JNK pathway. Immunol 2015; 194: 1239–51.

Xing C, Yuan Y, Ningzhu L, et al. Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155. J Mol Cell Biol 2012; 4: 341–3.

Zhang P, Wang H, Luo X, et al. MicroRNA-155 inhibits polarization of macrophages to M2-type and suppresses choroidal neovascularization. Inflammation 2018; 41: 143–53.

Martinez-Nunez RT, Louafi F, Sanchez-Elsner T. The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). J Biol Chem 2011; 286: 1786–94.

Banerjee S, Xie N, Cui H, et al. MicroRNA let-7c regulates macrophage. J Immunol 2013; 190: 6542–9.

Bras JP, Silva AM, Calin GA, et al. miR-195 inhibits macrophages pro-inflammatory profile and impacts the crosstalk with smooth muscle cells. PLoS One 2017; 12: e0188530.

Ying W, Tseng A, Chang RC, et al. Micro­RNA-223 is a crucial mediator of PPARγ-regulated alternative macrophage activation. J Clin Invest 2015; 125: 4149–59.

Zhuang G, Meng C, Guo X, et al. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 2012; 125: 2892–903.

Nefedova NA, Davidova SU. The role of vascular endothelial growth factor and hypoxia-inducible factor in tumor`s angiogenesis. Modern Problems Sci Edu 2015; (3): 51 (in Russian).

He C, Carter AB. The metabolic prospective and redox regulation of macrophage polarization. J Clin Cell Immunol 2015; 6: 371–7.

Lan J, Sun L, Xu F, et al. M2 macrophage-derived exosomes promote cell migration and invasion in colon cancer. Cancer Res 2019; 79: 146–58.

Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012; 122: 787–95.

Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436–44.

Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005; 7: 211–7.

Monastyrskaya EA, Lyamina SV, Malyshev IYu. Ml and М2 phenotypes of activated macrophages and their role in immune response and pathology. Pathogenesis 2008; 6: 31–9 (in Russian).

Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958–69.

Skivka LM, Gorbik GV, Fedorchuk OG, Pozur VV. Tumor-associated macrophages in the perspective of developing methods of cancer target therapy. Cytology Genetics (Ukr) 2009; 43: 71–82 (in Ukrainian).

Suarez-Lopeza L, Srirama G, Konga YW, et al. MK2 contributes to tumor progression by promoting M2 macrophage polarization and tumor angiogenesis. Proc Natl Acad Sci USA 2018; 115: E4236-E44.

Lyamina SV, Shimshelashvili ShL, Kalish SV, et al. Changes in phenotype and phenotypic flexibility of alveolar macrophages in inflammatory pulmonary diseases. Pul’monologiya 2012; (6): 83–9 (in Russian).

Kovaleva OV, Efremov GD, Mikhaylenko DS, et al. Role of tumor-associated macrophages in renal cell carcinoma pathogenesis. Cancer Urology 2017; 13: 20–6 (in Russian).

Genard G, Lucas S, Michiels C. Reprogramming of tumor-associated macrophages with anticancer therapies: radiotherapy versus chemo- and immunotherapies. Front Immunol 2017; 8: 828.

Komohara Y, Hasita H, Ohnishi K, et al. Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci 2011; 102: 1424–31.

Shu QH, Ge YS, Ma HX, et al. Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection. J Cell Mol Med 2016; 20: 1024–35.

Dong P, Ma L, Liu L, et al. CD86+/CD206+, diametrically polarized tumor-associated macrophages, predict hepatocellular carcinoma patient prognosis. Int J Mol Sci 2016; 17: 320.

Jackute J, Zemaitis M, Pranys D, et al. Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer. BMC Immunol 2018; 19: 3.

Xiaojuan W, Siyue N, Hui L, et al. Angiopoietin-like protein 2 facilitates non-small cell lung cancer progression by promoting the polarization of M2 tumor-associated macrophages. Am J Cancer Res 2017; 7: 2220–33.

Rath M, Müller I, Kropf P, et al. Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages. Front Immunol 2014; 5: 532.

Ivanchenko AV, Symchych TV, Fedosova NI, et al. Features of polarization of macrophages from different organs and tissues of mice with Lewis lung carcinoma. Oncology (Ukr) 2019; 21: 63–4 (in Ukrainian).




How to Cite

Karaman О., Ivanchenko, A., & Chekhun, V. (2023). Macrophages — a perspective target for antineoplastic immunotherapy. Experimental Oncology, 41(4), 282–290.



Original contributions

Most read articles by the same author(s)

1 2 > >>